230 related articles for article (PubMed ID: 19070991)
21. Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study.
Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1078-85. PubMed ID: 24726579
[TBL] [Abstract][Full Text] [Related]
22. Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients.
Karagianis J; Novick D; Pecenak J; Haro JM; Dossenbach M; Treuer T; Montgomery W; Walton R; Lowry AJ
Int J Clin Pract; 2009 Nov; 63(11):1578-88. PubMed ID: 19780867
[TBL] [Abstract][Full Text] [Related]
23. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome.
Lloyd K; Latif MA; Simpson S; Shrestha KL
Hum Psychopharmacol; 2010 Apr; 25(3):243-52. PubMed ID: 20373476
[TBL] [Abstract][Full Text] [Related]
24. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
Novick D; Haro JM; Bertsch J; Haddad PM
J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
[TBL] [Abstract][Full Text] [Related]
25. The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment.
Haro JM; Edgell ET; Jones PB; Alonso J; Gavart S; Gregor KJ; Wright P; Knapp M;
Acta Psychiatr Scand; 2003 Mar; 107(3):222-32. PubMed ID: 12580830
[TBL] [Abstract][Full Text] [Related]
26. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
[TBL] [Abstract][Full Text] [Related]
27. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.
Lambert M; Naber D; Schacht A; Wagner T; Hundemer HP; Karow A; Huber CG; Suarez D; Haro JM; Novick D; Dittmann RW; Schimmelmann BG
Acta Psychiatr Scand; 2008 Sep; 118(3):220-9. PubMed ID: 18699954
[TBL] [Abstract][Full Text] [Related]
28. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness and predictors of response to antipsychotic agents to treat impaired quality of life in schizophrenia: A 12-month naturalistic follow-up study with implications for confounding factors, antidepressants, anxiolytics, and mood stabilizers.
Ritsner MS; Gibel A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1442-52. PubMed ID: 16842897
[TBL] [Abstract][Full Text] [Related]
30. One-year functional outcomes of naturalistically treated patients with schizophrenia.
Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
[TBL] [Abstract][Full Text] [Related]
31. Remission in schizophrenia: results from a 1-year follow-up observational study.
Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
[TBL] [Abstract][Full Text] [Related]
32. Comparison of treatment discontinuation and hospitalization among nonadherent patients initiating depot or oral typical antipsychotic medications.
Novick D; Haro JM; Bertsch J; Anand H; Jemiai N; Haddad PM
Int Clin Psychopharmacol; 2012 Sep; 27(5):275-82. PubMed ID: 22699789
[TBL] [Abstract][Full Text] [Related]
33. Overview of the findings from the European SOHO study.
Suarez D; Haro JM
Expert Rev Neurother; 2008 Jun; 8(6):873-80. PubMed ID: 18505352
[TBL] [Abstract][Full Text] [Related]
34. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.
Stahl SM; Malla A; Newcomer JW; Potkin SG; Weiden PJ; Harvey PD; Loebel A; Watsky E; Siu CO; Romano S
J Clin Psychopharmacol; 2010 Aug; 30(4):425-30. PubMed ID: 20571437
[TBL] [Abstract][Full Text] [Related]
35. Symptomatic remission and patient quality of life in an observational study of schizophrenia: is there a relationship?
Haro JM; Novick D; Perrin E; Bertsch J; Knapp M
Psychiatry Res; 2014 Dec; 220(1-2):163-9. PubMed ID: 25194449
[TBL] [Abstract][Full Text] [Related]
36. Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
Landolt K; Rössler W; Ajdacic-Gross V; Derks EM; Libiger J; Kahn RS; Fleischhacker WW;
Schizophr Res; 2016 Apr; 172(1-3):145-51. PubMed ID: 26922655
[TBL] [Abstract][Full Text] [Related]
37. Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia.
Haro JM; Novick D; Belger M; Jones PB
Eur Psychiatry; 2006 Jan; 21(1):41-7. PubMed ID: 16414249
[TBL] [Abstract][Full Text] [Related]
38. What do large scale studies of medication in schizophrenia add to our management strategies?
Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
[TBL] [Abstract][Full Text] [Related]
39. Effects of antipsychotic medications on quality of life and psychosocial functioning in patients with early-stage schizophrenia: 1-year follow-up naturalistic study.
Guo X; Zhang Z; Zhai J; Fang M; Hu M; Wu R; Liu Z; Zhao J;
Compr Psychiatry; 2012 Oct; 53(7):1006-12. PubMed ID: 22516246
[TBL] [Abstract][Full Text] [Related]
40. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
